{"url_path":"/sec/dare/8-k/2026-09-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1401914/0001401914-26-000050-index.html","accession_number":"0001401914-26-000050","cik":"0001401914","ticker":"DARE","issuer_name":"Dare Bioscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1401914/0001401914-26-000050-index.html","primary_entity_key":"0001401914","primary_entity_name":"Dare Bioscience, Inc."},"word_count":83,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits\n\n(d) Exhibits\n\nExhibit No.\n\nDocument\n\n3.1\n\n[Amendment to Third Amended and Restated By-Laws of Daré Bioscience, Inc.](ex_31xdare-amendmenttobyla.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDARÉ BIOSCIENCE, INC.\n\n \n\nDated: September 11, 2026By:/s/ Sabrina Martucci Johnson\n\nName:Sabrina Martucci Johnson\n\nTitle:President and Chief Executive Officer"}